P A Grayburn

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi request reprint Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms
    P A Grayburn
    Division of Cardiology, University of Texas Southwestern Medical Center, Dallas 75216 9047, USA
    J Am Coll Cardiol 32:230-6. 1998
  2. ncbi request reprint Vasodilator therapy for chronic aortic and mitral regurgitation
    P A Grayburn
    Department of Internal Medicine, UT Southwestern Medical Center and VA Medical Center, Dallas, Texas 75235 9047, USA
    Am J Med Sci 320:202-8. 2000
  3. ncbi request reprint Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction
    I Afridi
    Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, USA
    J Am Coll Cardiol 32:921-6. 1998
  4. doi request reprint Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery
    S Chen
    Baylor Research Institute, Dallas, TX, USA
    Gene Ther 20:225-33. 2013
  5. ncbi request reprint Assessment of aortic regurgitation by transesophageal color Doppler imaging of the vena contracta: validation against an intraoperative aortic flow probe
    D L Willett
    Department of Internal Medicine, UT Southwestern Medical Center and Dallas VA Medical Center, Texas, USA
    J Am Coll Cardiol 37:1450-5. 2001
  6. ncbi request reprint Myocardial contrast agents: recent advances and future directions
    S Mayer
    Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75235-9047, USA
    Prog Cardiovasc Dis 44:33-44. 2001

Detail Information

Publications6

  1. ncbi request reprint Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms
    P A Grayburn
    Division of Cardiology, University of Texas Southwestern Medical Center, Dallas 75216 9047, USA
    J Am Coll Cardiol 32:230-6. 1998
    ....
  2. ncbi request reprint Vasodilator therapy for chronic aortic and mitral regurgitation
    P A Grayburn
    Department of Internal Medicine, UT Southwestern Medical Center and VA Medical Center, Dallas, Texas 75235 9047, USA
    Am J Med Sci 320:202-8. 2000
    ..In other primary causes of MR, vasodilators could potentially mask the development of LV dysfunction and lead to unnecessary and harmful delays in surgery...
  3. ncbi request reprint Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction
    I Afridi
    Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, USA
    J Am Coll Cardiol 32:921-6. 1998
    ....
  4. doi request reprint Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery
    S Chen
    Baylor Research Institute, Dallas, TX, USA
    Gene Ther 20:225-33. 2013
    ....
  5. ncbi request reprint Assessment of aortic regurgitation by transesophageal color Doppler imaging of the vena contracta: validation against an intraoperative aortic flow probe
    D L Willett
    Department of Internal Medicine, UT Southwestern Medical Center and Dallas VA Medical Center, Texas, USA
    J Am Coll Cardiol 37:1450-5. 2001
    ..Vena contracta width and VC area correlate well with RgF and RgV obtained by intraoperative flow probe. Vena contracta width appears to be less afterload-dependent than RgV...
  6. ncbi request reprint Myocardial contrast agents: recent advances and future directions
    S Mayer
    Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75235-9047, USA
    Prog Cardiovasc Dis 44:33-44. 2001
    ..In addition, the clinical trials involving these agents will also be discussed...